ANIK – Anika Therapeutics Inc.

Anika Therapeutics Inc.

ANIK

$14.57

Name : Anika Therapeutics Inc.

Sector : Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Mark. Cap: $193,862,944.00

EPSttm : -0.79

Anika Therapeutics Inc.

$14.57

0.21%

$0.03

ANIK — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

4.5

Margin Of Safety %

-26

Put/Call OI Ratio

0.03

EPS Next Q Diff

EPS Last/This Y

0.3

EPS This/Next Y

0.05

Price

14.61

Target Price

17.5

Analyst Recom

Performance Q

0.76

Upside

-289.8%

Beta

0.22

Ticker: ANIK

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	ANIK	14.52	0.05	0.00	438
2026-05-12	ANIK	14.67	0.05	0.00	437
2026-05-13	ANIK	14.77	0.05	0.00	438
2026-05-14	ANIK	15.34	0.05	0.00	438
2026-05-15	ANIK	14.9	0.05	0.00	438
2026-05-18	ANIK	14.93	0.02	1.00	417
2026-05-19	ANIK	14.83	0.03	0.00	425
2026-05-20	ANIK	15.12	0.03	0.00	425
2026-05-21	ANIK	15	0.03	0.00	425
2026-05-22	ANIK	14.86	0.03	0.00	425
2026-05-26	ANIK	14.86	0.03	0.00	425
2026-05-27	ANIK	14.79	0.03	0.00	426
2026-05-28	ANIK	14.87	0.03	0.00	427
2026-05-29	ANIK	14.53	0.03	1.00	428
2026-06-02	ANIK	14.37	0.03	0.00	430
2026-06-03	ANIK	14.41	0.03	0.00	430
2026-06-04	ANIK	14.78	0.03	0.00	430
2026-06-05	ANIK	14.47	0.03	999.99	432
2026-06-08	ANIK	14.57	0.03	0.00	433
2026-06-09	ANIK	14.59	0.03	0.00	435
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	ANIK	14.53	123.1	-	0.41
2026-05-12	ANIK	14.71	123.1	-	0.41
2026-05-13	ANIK	14.78	123.1	-	0.41
2026-05-14	ANIK	15.33	123.1	-	0.41
2026-05-15	ANIK	14.91	123.1	-	0.41
2026-05-18	ANIK	14.94	123.1	-	0.41
2026-05-19	ANIK	14.84	123.1	-	0.41
2026-05-20	ANIK	15.12	123.1	-	0.41
2026-05-21	ANIK	14.99	123.1	-	0.41
2026-05-22	ANIK	14.87	123.1	-	0.41
2026-05-26	ANIK	14.88	123.1	-	0.41
2026-05-27	ANIK	14.81	123.1	-	0.41
2026-05-28	ANIK	14.90	123.1	-	0.41
2026-05-29	ANIK	14.54	123.1	-	0.41
2026-06-01	ANIK	14.65	123.1	-	0.41
2026-06-02	ANIK	14.40	123.1	-	0.41
2026-06-03	ANIK	14.41	123.1	-	0.41
2026-06-04	ANIK	14.78	123.1	-	0.41
2026-06-05	ANIK	14.41	123.1	-	0.41
2026-06-08	ANIK	14.57	123.1	-	0.41
2026-06-09	ANIK	14.61	123.1	-	0.41
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	ANIK	2.43	0.41	5.13
2026-05-12	ANIK	2.37	0.41	4.40
2026-05-13	ANIK	2.37	0.41	4.40
2026-05-14	ANIK	2.37	0.41	4.40
2026-05-15	ANIK	2.37	0.41	4.40
2026-05-18	ANIK	2.37	-1.04	4.40
2026-05-19	ANIK	2.37	-1.04	4.40
2026-05-20	ANIK	2.37	-1.04	4.40
2026-05-21	ANIK	2.37	-1.04	4.40
2026-05-22	ANIK	2.37	-1.04	4.40
2026-05-26	ANIK	2.37	1.32	4.39
2026-05-27	ANIK	2.43	1.32	4.39
2026-05-28	ANIK	2.43	1.32	4.50
2026-05-29	ANIK	2.43	1.32	4.50
2026-06-02	ANIK	2.43	0.56	4.50
2026-06-03	ANIK	2.43	0.56	4.50
2026-06-04	ANIK	2.43	0.56	4.50
2026-06-05	ANIK	2.43	0.56	4.50
2026-06-08	ANIK	2.43	0.47	4.50
2026-06-09	ANIK	2.43	0.47	4.50
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.03

Avg. EPS Est. Next Quarter

0.03

Insider Transactions

2.43

Institutional Transactions

0.47

Beta

0.22

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

10.85

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

68.6

Max Drawdown 5-Year %

-82.5

Target Price

17.5

P/E

Forward P/E

PEG

1.15

P/S

1.67

P/B

1.45

P/Free Cash Flow

186.4

EPS

-0.79

Average EPS Est. Cur. Y

0.41

EPS Next Y. (Est.)

0.46

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-9.52

Relative Volume

0.51

Return on Equity vs Sector %

-35.7

Return on Equity vs Industry %

-16.3

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.16

EBIT Estimation

◆ ANIK Healthcare

$14.57

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

21/25

Volume

11/15

Valuation

14/20

TP/AR

2/10

Options

8/10

RSI

47.9

Range 1M

43%

Sup Dist

1.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

14/30

Estimates

1/20

Inst/Vol

4/15

Options

6/10

EPS Yr

-209.1%

EPS NY

229.2%

52W%

81.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +1.6% upside

Quality

6/30

Valuation

7/30

Growth

9/25

Stability

9/10

LT Trend

2/5

Upside

+1.6%

Quality

MoS

-26%

Anika Therapeutics Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 235

Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substitute, an HA-enhanced injectable bone repair therapy designed to treat insufficiency fractures and augment hardware fixation. It also provides Integrity, an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; non-orthopedic products, including Hyvisc, a high molecular weight injectable HA veterinary product for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine OA; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and ophthalmic products; and Anikavisc and Nuvisc high molecular weight HA products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.

ANIK

Latest News

—

Caricamento notizie per ANIK…

stock quote shares ANIK – Anika Therapeutics Inc. Stock Price stock today

news today ANIK – Anika Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ANIK – Anika Therapeutics Inc. yahoo finance google finance

stock history ANIK – Anika Therapeutics Inc. invest stock market

stock prices ANIK premarket after hours

ticker ANIK fair value insiders trading

ANIK – Anika Therapeutics Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ANIK

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y